GHRP-6 vs HGH (Somatropin)
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
Also: Growth Hormone Releasing Peptide 6, SKF-110679
GHRP-6 is a synthetic six-amino-acid peptide (His-D-Trp-Ala-Trp-D-Phe-Lys-NH2) that tricks the body into releasing its own growth hormone. It was one of the first growth hormone secretagogues ever made, and the hunt to find out why it worked led scientists straight to the discovery of ghrelin. It has no approval as a drug anywhere and is used only as a research compound.
Also: Somatropin, Human Growth Hormone
Human growth hormone is the real thing rather than a secretagogue: a 191-amino-acid protein identical to what your pituitary makes, produced recombinantly since the 1980s. It is a properly approved medicine for growth hormone deficiency, and it is also the most misused compound in this entire space. Almost everything you read about HGH for anti-aging or physique traces back to a single small 1990 study whose own author later disowned how it was used.
Key Comparison Insights
- HGH (Somatropin) is FDA approved, while GHRP-6 remains in research stages.
- Both peptides belong to the Growth Hormone category, suggesting similar primary applications.
- HGH (Somatropin) has stronger research evidence (FDA Approved) compared to GHRP-6 (Human Trials).
Detailed Comparison
| Attribute | GHRP-6 | HGH (Somatropin) |
|---|---|---|
| Category | Growth Hormone | Growth Hormone |
| FDA Status | Not FDA Approved | FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | GHRP-6 binds and activates the growth hormone secretagogue receptor type 1a (GHS-R1a), the same receptor later found to be the natural target of the hunger hormone ghrelin. When it switches that receptor on in the pituitary and hypothalamus, the pituitary fires off a pulse of growth hormone. Because GHS-R1a also sits on appetite-driving neurons in the brain (the NPY/AgRP cells of the arcuate nucleus), GHRP-6 is a strong appetite stimulant, more so than the other GHRPs. At higher doses it also nudges up cortisol and prolactin, since the receptor system is not perfectly selective for the GH pathway. | HGH binds the growth hormone receptor, mostly in the liver, which triggers IGF-1 release. IGF-1 does much of the work people associate with growth hormone: it drives cell growth, protein synthesis and cartilage growth. HGH itself acts directly on fat tissue, encouraging lipolysis, and it opposes insulin, which is why higher doses push blood sugar up and can create insulin resistance over time. The direct-versus-IGF-1 split matters practically: effects on fat come quickly and are largely direct, while effects on muscle and connective tissue are slower and IGF-1 mediated. This is also why HGH and IGF-1 LR3 are not interchangeable despite being linked. |
| Common Dosing | 100-300 mcg 2-3x daily 2-3x daily | 0.15-0.3 mg daily (clinical) or 2-4 IU daily (community) Once daily, typically evening |
| Administration | Subcutaneous injection, ideally fasted | Subcutaneous injection, usually daily, commonly in the evening to mimic natural nocturnal release |
| Typical Duration | 8-12 weeks | Clinical use is ongoing and monitored. Community cycles are typically reported as 3-6 months. |
| Best Time to Take | Before bed or morning (fasted) | Evening, before bed |
Possible Side Effects May vary by individual |
|
|
| Research Summary | GHRP-6 has been studied in humans, but mostly as a lab and diagnostic probe rather than as a treatment with large clinical trials behind it. Early work in the 1980s and 1990s showed it reliably triggers growth hormone release, and chasing its mechanism is literally what led Kojima and colleagues to discover ghrelin in 1999, which reframed how we understand hunger and GH control. A 2013 pharmacokinetic study in nine healthy men found oral bioavailability under 1 percent and an elimination half-life around 2.5 hours, which is why it is given by injection. The popular claims about muscle gain, fat loss, and healing in fitness circles are not backed by controlled human outcome trials. It is not approved by the FDA or EMA for any use and remains a research chemical, with appetite stimulation, water retention, and cortisol/prolactin bumps as known effects. | For diagnosed growth hormone deficiency the evidence is solid and decades deep: recombinant HGH restores body composition, bone density and quality of life in adults with genuine deficiency, and it is approved for that. For everyone else the picture is far weaker. The famous Rudman study in the New England Journal of Medicine in 1990 gave HGH to 12 older men for six months and reported gains in lean mass and reductions in fat, and that single small trial launched an entire anti-aging industry. It had no functional strength or performance endpoints, it was not designed to assess safety, and Rudman maintained until his death in 1994 that it carried no anti-aging implications. NEJM published an editorial in 2003 criticizing the industry that had grown up around citing it. Subsequent reviews of HGH in healthy older adults have found modest body composition changes alongside frequent side effects, with no demonstrated benefit to strength, function or longevity. Long-term supraphysiologic use carries real risks including insulin resistance and, at sustained high doses, acromegaly-like changes. |
Frequently Asked Questions: GHRP-6 vs HGH (Somatropin)
What is the difference between GHRP-6 and HGH (Somatropin)?
GHRP-6 is a growth hormone peptide that ghrp-6 is a synthetic six-amino-acid peptide (his-d-trp-ala-trp-d-phe-lys-nh2) that tricks the body into releasing its own growth hormone. it was one of the first growth hormone secretagogues ever made, and the hunt to find out why it worked led scientists straight to the discovery of ghrelin. it has no approval as a drug anywhere and is used only as a research compound. HGH (Somatropin) is a growth hormone peptide that human growth hormone is the real thing rather than a secretagogue: a 191-amino-acid protein identical to what your pituitary makes, produced recombinantly since the 1980s. it is a properly approved medicine for growth hormone deficiency, and it is also the most misused compound in this entire space. almost everything you read about hgh for anti-aging or physique traces back to a single small 1990 study whose own author later disowned how it was used. The main differences lie in their mechanisms of action and clinical applications.
Which is better, GHRP-6 or HGH (Somatropin)?
Neither is universally "better" - the choice depends on your specific goals. GHRP-6 is typically used for growth hormone purposes, while HGH (Somatropin) is used for growth hormone. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can GHRP-6 and HGH (Somatropin) be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using GHRP-6 and HGH (Somatropin) together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.